Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00460499 · ClinicalTrials.gov registry record · Phase 1
Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control
A Phase 1 study, sponsored by American Heart Association.
- Completed
- Registry status
- Phase 1
- Development phase
- 250
- Enrollment target
NCT00460499 is a Phase 1 study that has completed, run by American Heart Association. The registered enrollment target is 250 participants.
The verdict
NCT00460499, a Phase 1 study, has completed, sponsored by American Heart Association.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 250 participants
- Enrollment target
Study Summary
This study seeks to determine whether varying the dose of insulin and glucose in diabetic patients during coronary bypass surgery will improve outcomes in these patients.
Interventions
- DRUG A IV Insulin drip
- DRUG B Low Dose GIK
- DRUG C High Dose GIK
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2004-07 |
| Est. Completion | 2015-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00460499
The ClinicalTrials.gov registry entry for NCT00460499 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Heart Association, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which A IV Insulin drip is the first listed.
NCT00460499 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00460499 about?
NCT00460499 is a clinical study titled "Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control". This study seeks to determine whether varying the dose of insulin and glucose in diabetic patients during coronary bypass surgery will improve outcomes in these patients.
What is the current status of trial NCT00460499?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 250 participants. The study started on 2004-07. Estimated completion is 2015-03.
What interventions are being tested in trial NCT00460499?
The interventions under investigation include: A IV Insulin drip (DRUG), B Low Dose GIK (DRUG), C High Dose GIK (DRUG).
Who is sponsoring clinical trial NCT00460499?
This trial is sponsored by American Heart Association, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.